Likewise, cytogenetic abnormalities characteristic of B-ALL largely determine the biology of the disease, affect prognosis, and guide therapy.7 Presence of Ph+ BCR-ABL and MLL rearrangement are considered to have poor outcome. This evidence concerns the gene BCR and acute lymphoblastic leukemia.